4//SEC Filing
HARTOUNIAN HARTOUN 4
Accession 0001104659-24-074873
CIK 0001137883other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 9:04 PM ET
Size
8.0 KB
Accession
0001104659-24-074873
Insider Transaction Report
Form 4
HARTOUNIAN HARTOUN
EVP, Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-24+60,000→ 60,000 totalExercise: $0.38Exp: 2034-06-24→ Common Stock (60,000 underlying) - Award
Common Stock
2024-06-24+30,000→ 30,000 total
Footnotes (2)
- [F1]Represents shares of restricted stock units ("RSUs") awarded under the Issuer's 2014 Stock Incentive Plan (the "Plan"). The RSUs will vest in full on June 24, 2025, provided that the Reporting Person remains employed by Issuer from the date of grant through the vesting date.
- [F2]The option (the "Option"), awarded under the Plan, shall vest and become exercisable as to 25% of the underlying shares on June 24, 2025, and the remaining shares underlying the Option shall vest and become exercisable in equal quarterly installments thereafter, until fully vested and exercisable on the fourth anniversary of the grant date, provided that the Reporting Person remains employed by Issuer from the date of grant through each applicable vesting date.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001214476
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 9:04 PM ET
- Size
- 8.0 KB